Rafael Gonzalez, Ph.D. - Publications

Affiliations: 
University of California, Irvine, Irvine, CA 
Area:
spinal cord injury

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, Montenegro X, Gonzalez R, Silva F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies Cell Transplantation. 17: 1277-1293. PMID 19364066 DOI: 10.3727/096368908787648074  0.364
2007 Gonzalez R, Hickey MJ, Espinosa JM, Nistor G, Lane TE, Keirstead HS. Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice. Regenerative Medicine. 2: 771-83. PMID 17907930 DOI: 10.2217/17460751.2.5.771  0.68
2006 Glaser J, Gonzalez R, Sadr E, Keirstead HS. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. Journal of Neuroscience Research. 84: 724-34. PMID 16862543 DOI: 10.1002/Jnr.20982  0.682
2006 Hardison JL, Nistor G, Gonzalez R, Keirstead HS, Lane TE. Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Experimental Neurology. 197: 420-9. PMID 16297915 DOI: 10.1016/J.Expneurol.2005.10.016  0.586
2006 Gonzalez R, Hardison JL, Glaser J, Liu MT, Lane TE, Keirstead HS. The chemokine CXCL10 as a therapeutic target in animal models of neuroinflammatory disease Letters in Drug Design and Discovery. 3: 683-688. DOI: 10.2174/157018006778631839  0.592
2004 Glaser J, Gonzalez R, Perreau VM, Cotman CW, Keirstead HS. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. Journal of Neuroscience Research. 77: 701-8. PMID 15352216 DOI: 10.1002/Jnr.20204  0.682
2003 Gonzalez R, Glaser J, Liu MT, Lane TE, Keirstead HS. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Experimental Neurology. 184: 456-63. PMID 14637115 DOI: 10.1016/S0014-4886(03)00257-7  0.684
Show low-probability matches.